Atreca Inc Price Prediction
BCELDelisted Stock | USD 0.07 0.0005 0.70% |
Oversold Vs Overbought
32
Oversold | Overbought |
Atreca Inc stock price prediction is an act of determining the future value of Atreca shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Atreca's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Atreca and does not consider all of the tangible or intangible factors available from Atreca's fundamental data. We analyze noise-free headlines and recent hype associated with Atreca Inc, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether pink sheet price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Atreca based on different types of headlines from major news networks to social media. The Atreca stock price prediction module provides an analysis of price elasticity to changes in media outlook on Atreca over a specific investment horizon. Using Atreca hype-based prediction, you can estimate the value of Atreca Inc from the perspective of Atreca response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Atreca. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Atreca to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Atreca because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Atreca after-hype prediction price | USD 0.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Atreca |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Atreca's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Atreca After-Hype Price Prediction Density Analysis
As far as predicting the price of Atreca at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Atreca or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Atreca, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
Atreca Estimiated After-Hype Price Volatility
In the context of predicting Atreca's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Atreca's historical news coverage. Atreca's after-hype downside and upside margins for the prediction period are 0.07 and 0.08, respectively. We have considered Atreca's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Atreca is very steady at this time. Analysis and calculation of next after-hype price of Atreca Inc is based on 3 months time horizon.
Atreca Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Atreca is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Atreca backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Atreca, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 5 Events / Month | In 5 to 10 days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.07 | 0.07 | 1.41 |
|
Atreca Hype Timeline
Atreca Inc is currently traded for 0.07. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Atreca is forecasted to decline in value after the next headline, with the price expected to drop to 0.07. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -1.41%, whereas the daily expected return is currently at 0.0%. The volatility of related hype on Atreca is about 0.0%, with the expected price after the next announcement by competition of 0.07. About 25.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.28. Some equities with similar Price to Book (P/B) outperform the market in the long run. Atreca Inc recorded a loss per share of 2.5. The entity had not issued any dividends in recent years. The firm had 1:6 split on the 7th of June 2019. Given the investment horizon of 90 days the next forecasted press release will be in 5 to 10 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.Atreca Related Hype Analysis
Having access to credible news sources related to Atreca's direct competition is more important than ever and may enhance your ability to predict Atreca's future price movements. Getting to know how Atreca's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Atreca may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
PASG | Passage Bio | 0.03 | 7 per month | 4.15 | 0.09 | 9.68 | (6.43) | 41.15 | |
FIXX | Homology Medicines | 0.07 | 5 per month | 11.22 | 0.12 | 10.00 | (3.26) | 1,764 | |
STOK | Stoke Therapeutics | (0.69) | 7 per month | 4.64 | 0.15 | 22.86 | (8.17) | 64.17 | |
TCRR | Tcr2 Therapeutics | 0.06 | 8 per month | 3.26 | 0.05 | 5.77 | (6.25) | 43.60 | |
RVMD | Revolution Medicines | 0.65 | 10 per month | 2.05 | 0.14 | 4.32 | (3.82) | 14.22 | |
BDTX | Black Diamond Therapeutics | (0.19) | 7 per month | 4.35 | 0.16 | 15.50 | (7.18) | 26.97 | |
ALEC | Alector | (0.43) | 8 per month | 0.00 | (0.05) | 5.96 | (6.31) | 16.43 |
Atreca Additional Predictive Modules
Most predictive techniques to examine Atreca price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Atreca using various technical indicators. When you analyze Atreca charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Atreca Predictive Indicators
The successful prediction of Atreca stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Atreca Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Atreca based on analysis of Atreca hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Atreca's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Atreca's related companies. Story Coverage note for Atreca
The number of cover stories for Atreca depends on current market conditions and Atreca's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Atreca is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Atreca's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Atreca Short Properties
Atreca's future price predictability will typically decrease when Atreca's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Atreca Inc often depends not only on the future outlook of the potential Atreca's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Atreca's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 38.6 M | |
Cash And Short Term Investments | 70.5 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Atreca Inc information on this page should be used as a complementary analysis to other Atreca's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Atreca Pink Sheet
If you are still planning to invest in Atreca Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Atreca's history and understand the potential risks before investing.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |